In terms of Regulation 47 of SEBI LODR Regulations 2015, please find attached herewith the newspaper advertisement for the unaudited financial results for the quarter ended June 30, 2025.
BAYERCROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bayer CropScience has published its unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26) in four newspapers (Financial Express, Loksatta, Free Press Journal, and Navshakti) on August 8, 2025, as required by SEBI's listing regulations. Total income from operations rose to ₹19,146 million, up about 17% from ₹16,314 million in the same quarter last year. Net profit after tax grew roughly 10% year-on-year to ₹2,787 million (from ₹2,542 million), and earnings per share stood at ₹62.01 versus ₹56.56 in Q1 FY25. Equity share capital remained at ₹449 million and reserves stood at ₹28,055 million as of March 31, 2025. The filing is procedural — it merely republishes results that were already filed with the stock exchange under Regulation 33.
Routine compliance filing with no new information beyond already disclosed quarterly numbers. The underlying results show healthy double-digit revenue growth and steady profit growth, which is mildly positive for shareholders.